NEFF DEBORAH J 4
4 · Cytek Biosciences, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
NEFF DEBORAH J
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+47,013→ 47,013 totalExercise: $9.67Exp: 2032-06-01→ Common Stock (47,013 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest monthly over three years from the vesting commencement date of June 1, 2022. The option becomes fully vested on June 1, 2025.